文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

平均动脉压目标对脓毒性休克患者皮肤花斑及动脉乳酸正常化的影响:SEPSISPAM随机试验的事后分析

Effects of mean arterial pressure target on mottling and arterial lactate normalization in patients with septic shock: a post hoc analysis of the SEPSISPAM randomized trial.
PubMed 文献 · Ann Intensive Care · 2022-08-19
一句话结论与低平均动脉压目标(65~70 mmHg)相比,高平均动脉压目标(80~85 mmHg)未改变皮肤花斑和乳酸的变化过程;花斑持续≥6 h与28天和90天死亡风险显著升高相关。

该研究为SEPSISPAM随机试验的事后分析,纳入747例脓毒性休克患者,374例分入低平均动脉压组(65~70 mmHg),373例分入高平均动脉压组(80~85 mmHg)。自纳入后2 h起每2 h评估皮肤花斑直至停用儿茶酚胺。结果显示,两组前24 h内花斑和乳酸变化无差异;校正平均动脉压及混杂因素后,前24 h内花斑持续≥6 h与28天和90天死亡风险显著升高相关。无花斑或花斑<6 h且乳酸≥2 mmol/L的患者生存概率高于花斑≥6 h且乳酸<2 mmol/L的患者,提示花斑持续时间可能是比动脉乳酸更好的死亡标志物。

要点

  • 脓毒性休克患者高平均动脉压目标(80~85 mmHg)与低平均动脉压目标(65~70 mmHg)相比,前24 h花斑和乳酸变化无差异。
  • 校正平均动脉压及混杂因素后,前24 h内花斑持续≥6 h与28天和90天死亡风险显著升高相关。
  • 无花斑或花斑<6 h且乳酸≥2 mmol/L的患者生存概率高于花斑≥6 h且乳酸<2 mmol/L的患者。
  • 作者认为,与动脉乳酸相比,花斑持续时间似乎是更好的死亡标志物。
  • 花斑自纳入后2 h起每2 h评估一次,直至停用儿茶酚胺。

适用人群与场景

  • 脓毒性休克患者,来自SEPSISPAM随机试验,共纳入747例,低平均动脉压组374例,高平均动脉压组373例。

诊断标准与关键阈值

  • 低平均动脉压目标:65~70 mmHg;高平均动脉压目标:80~85 mmHg。
  • 花斑评估:自纳入后2 h起每2 h评估一次,直至停用儿茶酚胺。
  • 花斑持续时间分层:<6 h或≥6 h(前24 h内)。
  • 乳酸分层阈值:≥2 mmol/L或<2 mmol/L。

红旗征与不能漏的情况

  • 前24 h内花斑持续≥6 h与28天和90天死亡风险显著升高相关(校正平均动脉压及混杂因素后)。

研究设计与关键结果

  • 研究类型:SEPSISPAM随机试验的事后分析;样本量747例(低平均动脉压组374例,高平均动脉压组373例)。
  • 主要结果:两组前24 h内花斑和乳酸变化无差异。
  • 校正平均动脉压及混杂因素后,前24 h内花斑持续≥6 h与28天和90天死亡风险显著升高相关。
  • 无花斑或花斑<6 h且乳酸≥2 mmol/L的患者生存概率高于花斑≥6 h且乳酸<2 mmol/L的患者。

证据类型、等级与局限

  • 证据类型:随机对照试验(SEPSISPAM)的事后分析。
  • 作者结论:与低平均动脉压目标相比,高平均动脉压目标未改变花斑和乳酸变化过程;花斑持续>6 h与更高死亡率相关;与动脉乳酸相比,花斑持续时间似乎是更好的死亡标志物。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,与动脉乳酸相比,花斑持续时间似乎是更好的死亡标志物。
  • 高平均动脉压目标(80~85 mmHg)与低平均动脉压目标(65~70 mmHg)相比未改变花斑和乳酸变化过程。

指南或共识出处

  • SEPSISPAM随机试验的事后分析(Ann Intensive Care)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In patients with septic shock, the impact of the mean arterial pressure (MAP) target on the course of mottling remains uncertain. In this post hoc analysis of the SEPSISPAM trial, we investigated whether a low-MAP (65 to 70 mmHg) or a high-MAP target (80 to 85 mmHg) would affect the course of mottling and arterial lactate in patients with septic shock.

METHODS: The presence of mottling was assessed every 2 h from 2 h after inclusion to catecholamine weaning. We compared mottling and lactate time course between the two MAP target groups. We evaluated the patient's outcome according to the presence or absence of mottling.

RESULTS: We included 747 patients, 374 were assigned to the low-MAP group and 373 to the high-MAP group. There was no difference in mottling and lactate evolution during the first 24 h between the two MAP groups. After adjustment for MAP and confounding factors, the presence of mottling ≥ 6 h during the first 24 h was associated with a significantly higher risk of death at day 28 and 90. Patients without mottling or with mottling < 6 h and lactate ≥ 2 mmol/L have a higher probability of survival than those with mottling ≥ 6 h and lactate < 2 mmol/L.

CONCLUSION: Compared with low MAP target, higher MAP target did not alter mottling and lactate course. Mottling lasting for more than 6 h was associated with higher mortality. Compared to arterial lactate, mottling duration appears to be a better marker of mortality.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Fage N, Demiselle J, Seegers V, et al. Effects of mean arterial pressure target on mottling and arterial lactate normalization in patients with septic shock: a post hoc analysis of the SEPSISPAM randomized trial. Ann Intensive Care. 2022. PMID: 35984574. doi:10.1186/s13613-022-01053-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。